Related Experiment Video
Updated: Jun 6, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Covalent Inhibitors of KEAP1 with Exquisite Selectivity
Imre Fejes1, Piroska Markacz1, Janos Tatai1
1Servier Research Institute of Medicinal Chemistry, Zahony u. 7., H-1031 Budapest, Hungary.
Abstract:
The NRF2-KEAP1 interaction is central for cytoprotection against stresses, giving it high clinical significance. Covalent modification of KEAP1 is an efficient approach, but the covalent inhibitors used in the clinic carry undesired side effects originating in their moderate selectivity. Starting with a phenotypic screen, we identified a new covalent inhibitor chemotype that was optimized to deliver a series of potent and highly selective KEAP1 binders. While the developed compounds showed both cellular and in vivo activity, upregulating antioxidant response element-dependent target genes, they showed no genotoxicity in vitro. The lead compound exhibited broad selectivity in activity-based protein profiling and showed no significant interaction with a panel of commonly studied receptors nor with a broad panel of kinases. The nature of its interaction with KEAP1 and the origin of its selectivity were revealed by X-ray crystallography.
Related Concept Videos
Drug-Receptor Bonds
In...
Enzyme Inhibition
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Protein-protein Interfaces

